These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21075781)

  • 1. Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
    Byer SJ; Eckert JM; Brossier NM; Clodfelder-Miller BJ; Turk AN; Carroll AJ; Kappes JC; Zinn KR; Prasain JK; Carroll SL
    Neuro Oncol; 2011 Jan; 13(1):28-41. PubMed ID: 21075781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors.
    Ghadimi MP; Young ED; Belousov R; Zhang Y; Lopez G; Lusby K; Kivlin C; Demicco EG; Creighton CJ; Lazar AJ; Pollock RE; Lev D
    Clin Cancer Res; 2012 May; 18(9):2545-57. PubMed ID: 22407831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calebin-A induced death of malignant peripheral nerve sheath tumor cells by activation of histone acetyltransferase.
    Lee MJ; Tsai YJ; Lin MY; You HL; Kalyanam N; Ho CT; Pan MH
    Phytomedicine; 2019 Apr; 57():377-384. PubMed ID: 30831486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells.
    Li H; Zhang X; Fishbein L; Kweh F; Campbell-Thompson M; Perrin GQ; Muir D; Wallace M
    Cancer Biol Ther; 2010 Oct; 10(8):758-64. PubMed ID: 20699653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.
    Brosius SN; Turk AN; Byer SJ; Longo JF; Kappes JC; Roth KA; Carroll SL
    J Neuropathol Exp Neurol; 2014 Nov; 73(11):1078-90. PubMed ID: 25289889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
    Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
    Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of somatostatin receptors in peripheral nerve sheath tumors.
    Mawrin C; Schulz S; Hellwig-Patyk A; Kirches E; Roessner A; Lendeckel U; Firsching R; Vorwerk CK; Keilhoff G; Dietzmann K; Grimm K; Lindberg G; Gutmann DH; Scheithauer BW; Perry A
    J Neuropathol Exp Neurol; 2005 Dec; 64(12):1080-8. PubMed ID: 16319718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.
    Longo JF; Brosius SN; Black L; Worley SH; Wilson RC; Roth KA; Carroll SL
    Cell Commun Signal; 2019 Jul; 17(1):74. PubMed ID: 31291965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
    Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
    Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
    Ramkissoon A; Chaney KE; Milewski D; Williams KB; Williams RL; Choi K; Miller A; Kalin TV; Pressey JG; Szabo S; Azam M; Largaespada DA; Ratner N
    Clin Cancer Res; 2019 Jul; 25(13):4117-4127. PubMed ID: 30936125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.
    Park GH; Park E; Lee SJ; Lim K; Kim J; Park JE; Jeong SY
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
    Subramanian S; Thayanithy V; West RB; Lee CH; Beck AH; Zhu S; Downs-Kelly E; Montgomery K; Goldblum JR; Hogendoorn PC; Corless CL; Oliveira AM; Dry SM; Nielsen TO; Rubin BP; Fletcher JA; Fletcher CD; van de Rijn M
    J Pathol; 2010 Jan; 220(1):58-70. PubMed ID: 19890883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.
    Shen YC; Upadhyayula R; Cevallos S; Messick RJ; Hsia T; Leese MP; Jewett DM; Ferrer-Torres D; Roth TM; Dohle W; Potter BV; Barald KF
    Br J Cancer; 2015 Oct; 113(8):1158-67. PubMed ID: 26461061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An orthotopic xenograft model of intraneural NF1 MPNST suggests a potential association between steroid hormones and tumor cell proliferation.
    Perrin GQ; Li H; Fishbein L; Thomson SA; Hwang MS; Scarborough MT; Yachnis AT; Wallace MR; Mareci TH; Muir D
    Lab Invest; 2007 Nov; 87(11):1092-102. PubMed ID: 17876295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors.
    Friedrich RE; Nörnberg LKN; Hagel C
    Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
    Brossier NM; Carroll SL
    Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
    Holtkamp N; Mautner VF; Friedrich RE; Harder A; Hartmann C; Theallier-Janko A; Hoffmann KT; von Deimling A
    Acta Neuropathol; 2004 Feb; 107(2):159-68. PubMed ID: 14673600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral nerve sheath tumors from patients with neurofibromatosis type 1 do not have the chromosomal translocation t(X;18).
    Liew MA; Coffin CM; Fletcher JA; Hang MT; Tanito K; Niimura M; Viskochil D
    Pediatr Dev Pathol; 2002; 5(2):165-9. PubMed ID: 11910511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.